HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 23 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,159,000 | – | 834,054 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HighMark Wealth Management LLC | 6,966 | $7,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 57,454 | $59,000 | 0.00% |
| Virtu Financial LLC | 13,127 | $14,000 | 0.00% |
| UBS Group AG | 26 | $0 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 60 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 13 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 50 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 47,178 | $48,000 | 0.00% |
| STATE STREET CORP | 14,455 | $15,000 | 0.00% |